Total Payments
$74,990
2024 Payments
$38,957
Companies
19
Transactions
133
Medicare Patients
464
Medicare Billing
$50,783
Payment Breakdown by Category
Other$35,241 (47.0%)
Consulting$28,844 (38.5%)
Food & Beverage$5,212 (7.0%)
Travel$3,578 (4.8%)
Research$1,889 (2.5%)
Education$225.89 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $31,108 | 10 | 41.5% |
| Consulting Fee | $28,844 | 12 | 38.5% |
| Food and Beverage | $5,212 | 81 | 7.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,133 | 2 | 5.5% |
| Travel and Lodging | $3,578 | 13 | 4.8% |
| Unspecified | $1,889 | 8 | 2.5% |
| Education | $225.89 | 7 | 0.3% |
Payments by Type
General
$73,101
125 transactions
Research
$1,889
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | $33,744 | 17 | $0 (2024) |
| Corcept Therapeutics | $13,263 | 28 | $0 (2024) |
| Novo Nordisk Inc | $8,973 | 28 | $0 (2023) |
| Strongbridge US INC. | $6,634 | 16 | $0 (2019) |
| Xeris Pharmaceuticals, Inc. | $5,306 | 7 | $0 (2024) |
| Ascendis Pharma Inc | $2,132 | 1 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $1,470 | 2 | $0 (2021) |
| PFIZER INC. | $1,468 | 20 | $0 (2021) |
| Horizon Therapeutics plc | $1,260 | 1 | $0 (2021) |
| Shire North American Group Inc | $226.56 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,957 | 26 | RECORDATI_RARE_DISEASES_INC. ($23,509) |
| 2023 | $7,949 | 13 | Novo Nordisk Inc ($5,188) |
| 2022 | $3,707 | 9 | RECORDATI_RARE_DISEASES_INC. ($3,221) |
| 2021 | $9,513 | 8 | RECORDATI_RARE_DISEASES_INC. ($3,975) |
| 2020 | $3,445 | 10 | RECORDATI_RARE_DISEASES_INC. ($3,025) |
| 2019 | $2,630 | 20 | Corcept Therapeutics ($2,011) |
| 2018 | $7,017 | 26 | Strongbridge US INC. ($6,496) |
| 2017 | $1,772 | 21 | PFIZER INC. ($1,158) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Consulting Fee | Cash or cash equivalent | $4,680.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $91.95 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $74.36 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $108.30 | General |
| Category: ACROMEGALY | ||||||
| 07/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $97.94 | General |
| Category: Endocrinology | ||||||
| 06/19/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $383.13 | General |
| Category: Endocrinology | ||||||
| 06/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $6,750.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $4,000.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Travel and Lodging | Cash or cash equivalent | $383.13 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Travel and Lodging | Cash or cash equivalent | $303.96 | General |
| Category: ENDOCRINE AGENT | ||||||
| 06/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $112.53 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $110.14 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $41.27 | General |
| Category: Endocrinology | ||||||
| 05/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Endocrinology | ||||||
| 05/23/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 05/22/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,897.00 | General |
| Category: Endocrinology | ||||||
| 05/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $95.35 | General |
| Category: Endocrinology | ||||||
| 05/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Endocrinology | ||||||
| 04/22/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 04/18/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $5,523.59 | General |
| Category: Endocrinology | ||||||
| 04/18/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $173.10 | General |
| Category: ENDOCRINE AGENT | ||||||
| 03/18/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $111.53 | General |
| Category: ACROMEGALY | ||||||
| 03/07/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Honoraria | Cash or cash equivalent | $4,125.00 | General |
| Category: ENDOCRINE AGENT | ||||||
| 03/07/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Travel and Lodging | Cash or cash equivalent | $837.71 | General |
| Category: ENDOCRINE AGENT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study 455 | Corcept Therapeutics | $1,889 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 173 | 209 | $72,453 | $18,556 |
| 2021 | 4 | 186 | 235 | $83,667 | $21,400 |
| 2020 | 5 | 105 | 138 | $45,874 | $10,826 |
Total Patients
464
Total Services
582
Medicare Billing
$50,783
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 78 | $23,322 | $5,924 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 31 | 43 | $18,447 | $5,201 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 36 | $9,936 | $2,186 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 16 | $6,864 | $2,033 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 21 | $6,279 | $1,934 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $7,605 | $1,278 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 75 | 100 | $29,900 | $7,911 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 46 | $19,734 | $5,639 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 39 | 39 | $19,773 | $4,435 | 22.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 30 | $8,280 | $1,820 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 20 | $5,980 | $1,595 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 39 | 53 | $15,847 | $3,612 | 22.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 23 | 31 | $13,299 | $2,863 | 21.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 16 | 16 | $8,112 | $1,838 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 26 | $7,176 | $1,665 | 23.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,440 | $848.30 | 58.9% |
About Dr. Atil Kargi, M.D
Dr. Atil Kargi, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902918949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atil Kargi, M.D has received a total of $74,990 in payments from pharmaceutical and medical device companies, with $38,957 received in 2024. These payments were reported across 133 transactions from 19 companies. The most common payment nature is "Honoraria" ($31,108).
As a Medicare-enrolled provider, Kargi has provided services to 464 Medicare beneficiaries, totaling 582 services with total Medicare billing of $50,783. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Chapel Hill, NC
- Active Since 08/31/2006
- Last Updated 01/18/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1902918949
Products in Payments
- ISTURISA (Drug) $26,744
- Korlym (Drug) $11,374
- MACRILEN (Drug) $6,496
- Norditropin (Biological) $5,317
- RECORLEV (Drug) $5,184
- SKYTROFA (Drug) $2,132
- SOMAVERT (Drug) $1,468
- SOMATULINE DEPOT (Drug) $1,420
- TEPEZZA (Drug) $1,260
- MYCAPSSA (Drug) $301.59
- KEVEYIS (Drug) $137.44
- GVOKE HYPOPEN (Drug) $121.86
- ELIQUIS (Drug) $112.40
- NATPARA (Drug) $107.19
- Sogroya (Biological) $32.27
- INVOKANA (Drug) $23.73
- Repatha (Biological) $20.06
- ENTRESTO (Drug) $18.70
- BD Nano (Device) $13.89
- Omnipod (Device) $13.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Chapel Hill
Dr. John Buse, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $569,574
Endocrinology, Diabetes & Metabolism $569,574
Sadia Ejaz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $14,296
Endocrinology, Diabetes & Metabolism $14,296
Dr. Rebecca Vitale, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,000
Endocrinology, Diabetes & Metabolism $5,000
Dr. Janet Rubin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,818
Endocrinology, Diabetes & Metabolism $3,818
Karla Pou, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $478.70
Endocrinology, Diabetes & Metabolism $478.70
Tahereh Ghorbani Rodriguez, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $432.76
Endocrinology, Diabetes & Metabolism $432.76